United States · FDA National Drug Code directory
Cefotaxime
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 21586-012_7a77a18a-3d8c-4bac-8d21-54a88db396f6
- Product NDC
- 21586-012
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- cefotaxime injection
- Labeler
- SteriMax Inc.
- Marketing category
- UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
- Marketing start / end (source format)
- 20190801
- Source listing expiry
- 20271231
Source-listed ingredients
- CEFOTAXIME SODIUM — 2 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 PACKAGE (21586-012-02) / 1 POWDER, FOR SOLUTION in 1 VIAL (21586-012-01) · 21586-012-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →